Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis B Silverman

Showing results (121-130 of 188) with videos related to

Pageof 19
Sort By:
Pediatric Blood & Cancer|April 1, 2018
Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemiaAndrew E Place, Yana Pikman, Kristen E Stevenson, et al.
Blood|May 22, 2009
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Takaomi Sanda, Ruta Grebliunaite, et al.
Pediatric Blood & Cancer|September 7, 2022
Feasibility of oncology clinical trial-embedded evaluation of social determinants of healthRahela Aziz-Bose, Daniel J Zheng, Puja J Umaretiya, et al.
The New England Journal of Medicine|July 13, 2004
The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemiaSteven E Lipshultz, Nader Rifai, Virginia M Dalton, et al.
Blood|August 7, 2009
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocolMarieke H van der Linden, Maria Grazia Valsecchi, Paola De Lorenzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2020
Protective Effects of Dietary Intake of Antioxidants and Treatment-Related Toxicity in Childhood Leukemia: A Report From the DALLT CohortElena J Ladas, Traci M Blonquist, Maneka Puligandla, et al.
Pediatric Blood & Cancer|August 12, 2024
Supplemental Nutrition Assistance Program participation gaps within a pediatric leukemia clinical trial cohortRahela Aziz-Bose, Colin Cernik, Puja J Umaretiya, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2011
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL ConsortiumLynda M Vrooman, Donna S Neuberg, Kristen E Stevenson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2012
Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomesSteven E Lipshultz, Tracie L Miller, Rebecca E Scully, et al.
Pediatric Blood & Cancer|April 26, 2018
Reply to comment on: Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemiaMaria Luisa Sulis, Traci M Blonquist, Kristen E Stevenson, et al.
Pageof 19

Showing results (121-130 of 188) with videos related to

Sort By:
Pageof 19
Pediatric Blood & Cancer|April 1, 2018
Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemiaAndrew E Place, Yana Pikman, Kristen E Stevenson, et al.
Blood|May 22, 2009
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Takaomi Sanda, Ruta Grebliunaite, et al.
Pediatric Blood & Cancer|September 7, 2022
Feasibility of oncology clinical trial-embedded evaluation of social determinants of healthRahela Aziz-Bose, Daniel J Zheng, Puja J Umaretiya, et al.
The New England Journal of Medicine|July 13, 2004
The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemiaSteven E Lipshultz, Nader Rifai, Virginia M Dalton, et al.
Blood|August 7, 2009
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocolMarieke H van der Linden, Maria Grazia Valsecchi, Paola De Lorenzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2020
Protective Effects of Dietary Intake of Antioxidants and Treatment-Related Toxicity in Childhood Leukemia: A Report From the DALLT CohortElena J Ladas, Traci M Blonquist, Maneka Puligandla, et al.
Pediatric Blood & Cancer|August 12, 2024
Supplemental Nutrition Assistance Program participation gaps within a pediatric leukemia clinical trial cohortRahela Aziz-Bose, Colin Cernik, Puja J Umaretiya, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2011
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL ConsortiumLynda M Vrooman, Donna S Neuberg, Kristen E Stevenson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2012
Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomesSteven E Lipshultz, Tracie L Miller, Rebecca E Scully, et al.
Pediatric Blood & Cancer|April 26, 2018
Reply to comment on: Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemiaMaria Luisa Sulis, Traci M Blonquist, Kristen E Stevenson, et al.
Pageof 19